In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


jane departure

This article was originally published in The Rose Sheet

Executive Summary

Sandy Cataldo has resigned as president of jane cosmetics, effective Aug. 2, Estee Lauder division announces. A successor has not yet been named. Cataldo, who took the helm in June 2001, was tasked with improving sales and profits for the struggling mass market teen cosmetics brand. Coinciding with her appointment, Lauder also initiated a $16 mil. restructuring of the business (1"The Rose Sheet" July 2, 2001, p. 4). In her 10 years with Lauder, Cataldo also served as VP-marketing for Clinique USA and Canada and senior VP-marketing for the Estee Lauder brand...

You may also be interested in...

Cataldo joins Bath & Body Works

Sandy Cataldo appointed Bath & Body Works senior VP of emerging markets, Limited Brands announces Aug. 30. Effective immediately, Cataldo will report to Exec VP and General Merchandise Manager Michael Stromberg. Cataldo joins BBW from Estee Lauder, where she most recently worked as president of jane cosmetics. Cataldo, who spent 10 years with Lauder also working for Clinique and Estee Lauder brands, resigned Aug. 2 (1"The Rose Sheet" Aug. 19, 2002, In Brief)...

Lauder's Jane Restructuring Effort Involves $16 Mil. Charge In Q4

Estee Lauder will take a one-time $16 mil. charge in the fiscal fourth quarter (ended June 30) for a restructuring effort aimed at boosting sales and profits for its jane brand of mass market cosmetics, President and CEO Fred Langhammer said during a conference call June 28.

Goldman Sachs Gains 2 Board Seats With Burst Subscription Oral Care Investment

Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts